Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Almost three quarters of women with rheumatoid arthritis worldwide suffer pain daily

June 16, 2010 6:41 am | by EurekAlert | News | Comments

(European League Against Rheumatism) Almost three quarters (72 percent) of women with rheumatoid arthritis suffer pain daily, despite the fact that three quarters (75 percent) receive pain relief medication, according to a new study presented today at EULAR 2010, the Annual...

TOPICS:

Riverside Health System Benefits from New Model of Care Facilitation Powered by Curaspan Health Group

June 16, 2010 6:39 am | by Bio-Medicine.Org | News | Comments

NEWTON, Mass. , June 16 /- Curaspan Health Group , the industry leader in building secure electronic patient-transition networks for hospitals, post-acute providers and suppliers, has helped Riverside Health System (RHS) dramatically increase referrals within its network. In one year,...

TOPICS:

Simbionix Welcomes Two New Members to Expand Compay's Medical Education Product Offerings

June 16, 2010 6:39 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Ohio , June 16, 2010 /- Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is pleased to announce that Marc Schwachter M.D ., and Paul DeLuca have joined the...

TOPICS:
Advertisement

New Publications Highlight LifeNet Health's Life Saving Work in Neurosurgery

June 16, 2010 6:39 am | by Bio-Medicine.Org | News | Comments

VIRGINIA BEACH, Va. , June 16 /- LifeNet Health, a leading allograft bio-implant and regenerative material company, is pleased to announce two key publications regarding its innovative OsteoCleanse™ autograft cleaning service for the treatment of infected or contaminated cranial...

TOPICS:

Predictive Biosciences Closes $25 million Series C round

June 16, 2010 6:37 am | by Mass Device | News | Comments

Predictive Biosciences plans to use its now-completed $25 million Series C round to begin commercializing its biomarker-based bladder cancer test. Predictive Biosciences completed a $25 million Series C round, saying it plans to use the money to complete clinical trials for its...

TOPICS:

Covidien paying $300 million for Somanetics(4)

June 16, 2010 6:13 am | by The Associated Press | News | Comments

Covidien PLC, which makes drugs and medical devices, said Wednesday it is buying its distribution partner Somanetics Corp. for almost $300 million.Covidien is currently the distributor for Somanetics' high-tech diagnostic equipment, called the INVOS Cerebral/Somatic Oximeter, in Europe, the...

TOPICS:

Additional Research and Findings Strengthen 510(k) Applications and Add Three New Products

June 16, 2010 6:10 am | News | Comments

BioElectronics Corporation (PINKSHEETS: BIEL), developers of innovative topical pain-relieving medical devices, announced today it is strengthening its U.S. FDA clearance applications with additional research and findings to better articulate its product classification, claims and improve its...

Tufts graduate students win $10,000 prizes

June 16, 2010 5:40 am | by EurekAlert | News | Comments

(Tufts University) Four Tufts graduate students have won $10,000 from the Dow Sustainability Innovation Student Challenge for their research into solutions to some of the world's most urgent social, economic and environmental challenges. Tufts is one of a select number of...

TOPICS:
Advertisement

ESC supports traffic light food labeling vote

June 16, 2010 5:40 am | by EurekAlert | News | Comments

(European Society of Cardiology) The European Society of Cardiology and its branch, the European Association for Cardiovascular Prevention and Rehabilitation, are joining forces with 12 other European Health and consumer communities to urge MEPs to vote in favor of a traffic light...

TOPICS:

FDA/CDRH Public Meeting: Oversight of Laboratory Developed Tests (LDTs), Date July 19-20, 2010

June 16, 2010 5:35 am | by U.S. Food & Drug Administration | News | Comments

Since the implementation of the 1976 Medical Device Amendments, the FDA has generally exercised enforcement discretion and not enforced applicable regulations with respect to LDTs, a class of in vitro diagnostics (IVDs) that are manufactured, including...

TOPICS:

Kinetic gets FDA clearance for surgical system(3)

June 16, 2010 5:12 am | by The Associated Press | News | Comments

Kinetic Concepts Inc., a medical technology company, said Wednesday it received Food and Drug Administration clearance to sell its Prevena Incision Management system used for surgical procedures.The product is a wound therapy device used to removing potentially infectious materials from...

TOPICS:

Covidien to pay $250 million for Somanetics

June 16, 2010 4:38 am | by Mass Device | News | Comments

Covidien plc agrees to pay $250 million in cash to acquire oximetry device maker Somanetics Corp. at $25 per share. Covidien plc (NYSE:COV) continued to streamline its medical device operations with the latest acquisition in a series of buys and sells: a $250 million cash...

TOPICS:

Covidien Announces Definitive Agreement to Acquire Somanetics Corporation

June 16, 2010 3:40 am | by Covidien | News | Comments

Expands monitoring platform with market-leading technology Complements existing sales infrastructure; geographic expansion opportunities Strong portfolio of clinical research DUBLIN & TROY, Mich., Jun 16, 2010 (BUSINESS WIRE) --Covidien plc (NYSE: COV) and Somanetics Corporation...

TOPICS:

Henry Schein to Present at the Goldman Sachs 31st Annual Global Healthcare Conference

June 16, 2010 3:40 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y. , June 16 /- Henry Schein , Inc., (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that Steven Paladino , the Company's Executive Vice President and Chief Financial Officer, will present at the Goldman...

TOPICS:

Isis Pharmaceuticals to Present at The Wells Fargo 2010 Healthcare Conference

June 16, 2010 3:40 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif. , June 16 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Wells Fargo's 2010 Healthcare Conference on Wednesday, June 23, 2010 at 2:00 p.m. ET at the InterContinental...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading